FDA Approved: ONDANSETRON — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

FDA approved Accord Healthcare, Inc.'s supplemental application for ondansetron, indicating an approved change to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting
• Radiation Therapy-induced Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)